The STRATUS trial (MM-010): A single-arm phase 3b study of pomalidomide plus low-dose dexamethasone (POM + LoDEX) in refractory or relapsed and refractory multiple myeloma.
Meletios A. Dimopoulos
Honoraria - Celgene; Ortho Biotech
Katja C. Weisel
Consultant or Advisory Role - Celgene; Janssen; Onyx
Honoraria - Celgene; Janssen; Onyx
Michele Cavo
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Millennium
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Millennium
Paolo Corradini
No relevant relationships to disclose
Michel Delforge
Consultant or Advisory Role - Celgene; Janssen-Cilag
Gareth J Morgan
Honoraria - Celgene
Research Funding - Celgene
Markus Hansson
No relevant relationships to disclose
Antonio Palumbo
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium; Onyx
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium; Onyx
Enrique M. Ocio
Research Funding - Celgene
Mathew Simcock
Employment or Leadership Position - Celgene
Neil Miller
Employment or Leadership Position - Celgene
Ana Slaughter
Employment or Leadership Position - Celgene
Nicolas Leupin
Employment or Leadership Position - Celgene
Zariana G. Nikolova
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Other Remuneration - Celgene
Philippe Moreau
Consultant or Advisory Role - Celgene (I); Celgene